Avid Bioservices Inc (CDMO)

[vinmantoo]

Vin, per usual, you fail to focus on the MSKCC(and NCCN(3) trials that have begun enrollment in humans)

PPHM has ZERO trials in progress. No numbers have been announced for any of the PROPOSED studies you cited.

I will ask you again a question you have failed to answer... do you doubt Dr. Wolchok's and his MSKCC teams' capability to enter Bavituximab family derivative(s) into clinical trials in humans, predicated on results and conclusions MSKCC and PPHM demonstrated in ACCR 2017 abstract/poster #1654 presented in April 2017? Tell us why if you wish to cast doubt.

Be my guest if you want to tout some trivial pre-clinical data.